The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

FromGoldman Sachs Exchanges

Start listening View podcast show

The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

FromGoldman Sachs Exchanges

ratings:

Length:

27 minutes

Released:

Nov 7, 2023

Format:

Podcast episode

Description

Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.

Released:

Nov 7, 2023

Format:

Podcast episode

Titles in the series (100)

In each episode of "Exchanges at Goldman Sachs," people from the firm share their insights on developments shaping industries, markets and the global economy.

Skip carousel

Billion Dollar Babies: Virtual Reality and the Shift to Cloud: An exchange on virtual reality and the cloud by Goldman Sachs Exchanges
23 min listen
The Future of Finance: An exchange on the way we pay, lend and bank by Goldman Sachs Exchanges
30 min listen
The UK Macro Environment: An exchange on the growth outlook in the UK by Goldman Sachs Exchanges
13 min listen
A Revolution in Cancer Treatment: An exchange on some of the latest developments in healthcare by Goldman Sachs Exchanges
13 min listen
A Conversation with Lloyd Blankfein: An exchange on key themes for the global economy by Goldman Sachs Exchanges
30 min listen
The State of the Markets: Gary Cohn on Interest Rates, Liquidity and Risk Management: An exchange with our president and chief operating officer by Goldman Sachs Exchanges
25 min listen
Disruption in Deutschland: An exchange on the German business environment by Goldman Sachs Exchanges
25 min listen
Niche No Longer: ESG Investing Goes Mainstream: An exchange on ESG investing by Goldman Sachs Exchanges
29 min listen
Revitalizing Communities Through Impact Investing: An exchange on impact investing by Goldman Sachs Exchanges
19 min listen
Global Equity Markets in Flux: An exchange with our president and chief operating officer by Goldman Sachs Exchanges
22 min listen
The Business Case for Climate Action: An exchange on the Paris climate agreement and turning global urgency into action by Goldman Sachs Exchanges
27 min listen
Planes, Brains and Automobiles: The Future of Innovation: An exchange on industry-disrupting innovations by Goldman Sachs Exchanges
19 min listen
The Digitization of Finance: An exchange on tech and finance by Goldman Sachs Exchanges
27 min listen
The Global Growth Landscape: An exchange on developments influencing global growth by Goldman Sachs Exchanges
18 min listen
Brittle Markets: The Risks from Falling Liquidity: An exchange on market liquidity by Goldman Sachs Exchanges
26 min listen
"Fat and Flat" and the Market Path from Here: An exchange on equity markets by Goldman Sachs Exchanges
27 min listen
The Store of the Future: The store adapts to an age of e-commerce by Goldman Sachs Exchanges
20 min listen
Flat is the New Up: An exchange on a new expectations for global markets by Goldman Sachs Exchanges
27 min listen
Oil: Lower for Even Longer: An exchange on global commodity markets by Goldman Sachs Exchanges
23 min listen
Charting the Course for a Stronger South Africa: An exchange on South Africa and the broader region by Goldman Sachs Exchanges
24 min listen
Artificial Intelligence: The Next Wave of Disruption: An exchange on the economic potential of Growth Markets around the world by Goldman Sachs Exchanges
18 min listen
Half Full: The Case for Remaining Invested in US Equities: Why there's reason to be optimistic about US equities by Goldman Sachs Exchanges
29 min listen
Cord Cutting Goes Prime Time: An exchange on the way we watch by Goldman Sachs Exchanges
25 min listen
The Evolution of the 'Long Good Buy': An exchange on global equity markets by Goldman Sachs Exchanges
20 min listen
The Bear Necessities: Why equity investors must keep an eye on inflation. by Goldman Sachs Exchanges
26 min listen
How Fintech Is Transforming Consumer Finance: An exchange on the consumer credit landscape by Goldman Sachs Exchanges
27 min listen
The Future of the US-China Economic Relationship: An exchange on the US-China investment relationship by Goldman Sachs Exchanges
26 min listen
Mutant Mosquitoes, 'Peak Stuff' and the Shifting Currents of Innovation: An exchange on the sharing economy, drones and more by Goldman Sachs Exchanges
20 min listen
Beyond the Fed Hike: The Business of Banking in 2016: An exchange on key trends for US banks by Goldman Sachs Exchanges
22 min listen
Healthcare's Balance Between Science and Commerce: An exchange on trends in the healthcare sector by Goldman Sachs Exchanges
20 min listen

More Episodes from Goldman Sachs Exchanges

Skip carousel

Weighing the GLP-1 Market by Goldman Sachs Exchanges
24 min listen
Are inflation fears overblown? The outlook for inflation, US growth, and long-term rates by Goldman Sachs Exchanges
22 min listen
Global insurers turn to private credit — and AI by Goldman Sachs Exchanges
20 min listen
Capital Group’s Rob Lovelace on long-term investing, succession planning, and leadership lessons by Goldman Sachs Exchanges
43 min listen
Are the largest US stocks too dominant? by Goldman Sachs Exchanges
19 min listen
Global transit & trade: in rough waters by Goldman Sachs Exchanges
33 min listen
High mortgage rates, limited inventory continue to challenge the US housing market by Goldman Sachs Exchanges
21 min listen
What’s ahead for retail: how retail CEOs are navigating a more complex environment by Goldman Sachs Exchanges
37 min listen
Beyond roads, bridges, and tunnels: the megatrends shaping infrastructure investments by Goldman Sachs Exchanges
24 min listen
Dimensional’s Founder and Chairman David Booth on being an index pioneer, working with Nobel laureates, and investing through uncertainty by Goldman Sachs Exchanges
36 min listen
Shifting supply and demand dynamics buffer oil market by Goldman Sachs Exchanges
21 min listen
2024: the year of elections by Goldman Sachs Exchanges
26 min listen
Investing in a post-modern ‘super cycle’ by Goldman Sachs Exchanges
23 min listen
The Future of Four Wheels: Episode 4, How a New Kind of Car Will Change Our World by Goldman Sachs Exchanges
29 min listen
The Future of Four Wheels: Episode 3, The New New-Car Business by Goldman Sachs Exchanges
35 min listen
The Future of Four Wheels: Episode 2, Building the Car of the Future by Goldman Sachs Exchanges
29 min listen
The Future of Four Wheels: Episode 1, The Twin Revolution by Goldman Sachs Exchanges
26 min listen
Goldman Sachs Chairman and CEO David Solomon on the global economy, the deal-making environment, and the firm’s strategic priorities by Goldman Sachs Exchanges
20 min listen
America Powers On: Why US equities are still poised to outperform in 2024 by Goldman Sachs Exchanges
22 min listen
US presidential elections outlook: Implications for policy and markets by Goldman Sachs Exchanges
27 min listen
KKR’s Henry Kravis on private equity, culture, and global markets by Goldman Sachs Exchanges
54 min listen
Uncharted territory: Navigating a ‘geopolitical recession’ by Goldman Sachs Exchanges
35 min listen
Asset allocation outlook: The case for greater portfolio diversification in 2024 by Goldman Sachs Exchanges
33 min listen
Focus on financials: Why banks and asset managers are constructive about the economy in 2024 by Goldman Sachs Exchanges
28 min listen
Middle East risks by Goldman Sachs Exchanges
26 min listen
M&A in 2024: Navigating opportunities and challenges by Goldman Sachs Exchanges
20 min listen
Blackstone’s Kathleen McCarthy on the forces shaping the real estate industry by Goldman Sachs Exchanges
52 min listen
What China’s struggling property sector means for the global economy and markets by Goldman Sachs Exchanges
28 min listen
What’s the outlook for deal-making, corporate and investor sentiment, and markets? by Goldman Sachs Exchanges
36 min listen
Why the global economy and markets can continue to outperform in 2024 by Goldman Sachs Exchanges
29 min listen

Related podcast episodes

Skip carousel

Bonus Feature: Genesis of disease with Dr Mark Houston by FX Medicine Podcast Central
20 min listen
3 in 15: Healthcare category insights by The WARC Podcast
21 min listen
S3 Ep6: Fmr. FDA Commissioner Dr. Scott Gottlieb on Improving Public Health Through Innovation and Regulation by The Minor Consult
29 min listen
Podcast from Washington: Surgeon General’s Call to Action to Control Hypertension: In this week’s episode of Podcast from Washington, NACCHO government affairs team members Ian Goldstein and Eli Briggs discuss the outcome of the 2020 election and the balance of power in Congress. They also discuss the election implications for the... by The NACCHO Podcast Series
19 min listen
Removing Roadblocks: Addressing the US Physician Shortage and Empowering International Medical Talent by Healthcare Americana
31 min listen
The Business Objective of Medical Affairs with Holly Schachner, MD: During this episode of Medical Affairs unscripted, Dr. Crowley-Nowick has a conversation with Holly Schachner, MD, former CMO of Specialty Medicine at Allergan to examine the business objective of Medical Affairs (MA) organizations and how MA can move... by Medical Affairs Unscripted
33 min listen
Frakt on Medicaid and the Oregon Medicaid Study: Austin Frakt talks with host Russ Roberts about Medicaid and the recent results released from the Oregon Medicaid study, a randomized experiment that looked at individuals with and without access to Medicaid. Recent released results from that study found no significant impact of Medicaid access on basic health measures such as blood pressure and cholesterol levels, but did find reduced financial stress and better mental health. Frakt gives his interpretation of those results and the implications for the Affordable Care Act. The conversation closes with a discussion of the reliability of empirical work in general and how it might or might not affect our positions on social and economic policy. by EconTalk
69 min listen
How China has grown through innovation to rival the US market by Conversations in Healthcare
30 min listen
The Wellness of Wellbeing by 1 Giant Mind Podcast with Jonni Pollard
23 min listen
Comparing exercise and drugs for hypertension with Dr Huseyin Naci. Episode #361: Did you know that one in four people have hypertension? And with recent changes to diagnostic criteria in major clinical practice guidelines, the prevalence is only going to increase. With concerns about the cost, effectiveness, and potential for sid... by BJSM Podcast
21 min listen
Sandra Scheinbaum, PhD: Health Coaching by Healthcare Americana
33 min listen
ACCEL Lite: How Do I Implement the New 2022 ACC HF Guidelines Into My Practice?: The highly anticipated newest iteration of the Chronic Heart Failure Guidelines are finally here. What updates are most important to clinicians, and how can they be most effectively implemented in clinical practice? In this interview, Michelle... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
17 min listen
From Prescription to OTC and back again: What do Switches mean for Certain Drugs?: In this episode of Globalcast, Head of Global Consumer Health Research, Samantha Chmelik, discusses “switching” in the consumer health industry and what switches could occur in the near future. Hear about: What a "switch" is in regards... by Euromonitor Podcasts
5 min listen
81. Innovation at Johnson & Johnson: A Conversation with Dr. William Hait: In this episode, , Global Head of Johnson & Johnson External Innovation, discusses how the 135 year old company is using the principles of disruption to improve the trajectory of healthcare across the globe. Dr. Hait, who leads a unit comprised of... by The Disruptive Voice
33 min listen
The Patient Priority with Stefan Larsson and Jennifer Clawson by Thinkers & Ideas
25 min listen
The Future of the Healthcare Sector by Inside Social Innovation
20 min listen
Podcast from Washington: Global Health Security Podcast Part 2 Adopting Vector Control Initiatives to a U.S. Context with Dr. Umair Shah: In this week’s episode of Podcast from Washington, NACCHO Government Affairs team members Ian Goldstein and Eli Briggs discuss the latest from Capitol Hill and recent hearings on e-cigarettes, vaccines, and emergency preparedness. ... by The NACCHO Podcast Series
26 min listen
From Humble Beginnings to Potential Treatment for ALS: The co-founders and CEOs of Amylyx Pharmaceuticals return to discuss their latest new drug application for the treatment of ALS. by Vital Science
33 min listen
The global shift to decentralize healthcare: There is a global shift to decentralize healthcare — meeting patients where they are to receive the care they need. In this new episode of Healthcare Insider, Ron Emerson, Global Healthcare Lead at Zoom, and Ron Strachan, the Principal of Optimize... by Modern Healthcare’s Healthcare Insider Podcast
16 min listen
Tools for Healthcare Leaders - Dr. Hanadi Hamadi and Dr. Shyam Paryani, University of North Florida Brooks College of Health: “Question everything,” advises Dr. Hanadi Hamadi to future healthcare professionals, but “always remember your lines and your boundaries, your mental health.” In this episode of Raise the Line, Dr. Hamadi joins her colleague at Brooks College of Health Dr. Shyam Paryani and Osmosis' Shiv Gaglani to discuss current trends and recent happenings in healthcare reform and health policy. Tune in to discover what Dr. Hamadi and Dr. Paryani see as the most essential tools for future healthcare leaders. Plus, learn about Brooks College of Health's unique online Executive Master of Health Administration program directed at working professionals, the challenge for hospitals to provide population health and not just acute care as a result of the Affordable Care Act, Dr. Hamadi's research on evaluating the recent emphasis on social determinants of health, and the lasting cha by Raise the Line
25 min listen
Revolutionizing Healthcare: A Path to Patient Empowerment: In this episode of American Potential, host Jeff Crank delves into the complexities of the healthcare system with experts Brian Blase and Joe Grogan. They discuss the barriers to innovation and competition created by current healthcare policies and r... by American Potential
41 min listen
Retail Investors Beware: Not-So-Free Trading 9/2/22: The Labor Department released the number of American jobs added in August: 315,000. Only slightly below expectations, CNBC’s Steve Liesman and former CEA member Tyler Goodspeed consider what the report means for the Federal Reserve’s next rate hike. According to a new study by a group of professors, commission-free trades might not be free. UCLA Irvine Professor Christopher Schwartz explains the study, the fee and payout discrepancies between brokerages, and shares the best and the worst firms for retail trader pockets. As offices across the U.S. gear up for a reunion, China is locking down over 21 million people because of 700 covid cases. Former FDA Commissioner Dr. Scott Gottlieb discusses the difference between our approaches to public health, and shares which vaccines we should be getting–and when we should get them. Plus, Starbucks has named Howard Schultz’s successor, and Lululemon delivered a strong quarterly performance. I by Squawk Pod
26 min listen
Hedley Rees, Dabinderjit Singh & Deepa Singh on The Sonia Poulton Show - 25 January 2024: On today's show, Hedley Rees discusses how Glaxo-SmithKline and the Government Vaccine Task Force are linked. He delves into the depopulation agenda and sheds light on the essential information people need to know about Big Pharma. Later, Sikh activi... by TNT Radio
55 min listen
Medicare for All: Effects on Hospitals and Doctors - Part Three: with Thomas Nickels by Wharton Business Daily
10 min listen
Freeing Physicians Series, Part 2 by Healthcare Americana
18 min listen
Medical Crisis – Jack Rubinstein, Associate Professor of Medicine, University of Cincinnati – An Interesting Look at the Many Challenges and Problems in Today’s Medical and Pharmaceutical Industries: Jack Rubinstein, Associate Professor of Medicine, University of Cincinnati discusses his medical thriller, The Perfect Dose, and how it relates to real-world problems in the healthcare industry. Dr. Rubinstein is affiliated with multiple hospitals in... by Finding Genius Podcast
42 min listen
11/14/23: Fallout from Walgreens' cost-cutting scramble: Crain's health care reporter Katherine Davis talks with host Amy Guth about Walgreens' second round of corporate staff reductions in recent months, as well as a new role at the CDC for former Chicago health chief Dr. Allison Arwady. Plus: Mayor Johnson picks Arwady's replacement in the city's Public Health Department, Chicago's tallest apartment building goes up for sale, the clan that owns Napleton Automotive Group buys one of the most recognizable office properties in the suburbs and Chicago's top accounting firms see an average 7% uptick in headcount. by Crain's Daily Gist
23 min listen
S6 Ep8: Episode 8: Johnson & Johnson Center for Health Worker Innovation presents the ‘Future of Global Healthcare’ in association with The Conduit Episode 8: Alice Lin Fabiano by Conduit Conversations
30 min listen
Big Pharma: Patient Experience and Innovation: The pharmaceutical industry is evolving to consider customer experience – or patient experience, in this case – as a core dimension when bringing new drugs to market. Shifting consumer expectations combined with innovative technologies will have a... by CXOTalk
47 min listen
Nicole Hassoun, "Global Health Impact: Expanding Access to Essential Medicines" (Oxford UP, 2020): Every year nine million people are diagnosed with tuberculosis, every day over 13,400 people are infected with AIDs, and every thirty seconds malaria kills a child... by New Books in Public Policy
39 min listen

Discover this podcast and so much more

The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

Description

Titles in the series (100)

More Episodes from Goldman Sachs Exchanges

Related podcast episodes